United States · FDA National Drug Code directory

Dexlansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0378-2085_bd08545b-3f1d-44c5-bdd9-05acd7f69a0a
Product NDC: 0378-2085
Form: CAPSULE, DELAYED RELEASE PELLETS
Composition / generic term: dexlansoprazole
Labeler: Mylan Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20240122
Source listing expiry: 20261231

Source-listed ingredients

DEXLANSOPRAZOLE SESQUIHYDRATE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (0378-2085-93) · 0378-2085-93

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →